NJ
Nitin Jajodia
About Nitin Jajodia
Data last updated:
Nitin Jajodia is a Cfo at Rubicon Research Limited (since 2024) and Director at Kia Health Tech Private Limited (since 2021). The companies operate in Chemicals, Healthcare and Pharma. The largest current company by reported revenue is Rubicon Research Limited at ₹872 Cr (FY 2024). Earlier, Nitin Jajodia was a Director at Cipla Pharma And Life Sciences Limited (2015–2017) and Cfo at Cipla Health Limited (2019–2020).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Rubicon Research Limited L73100MH1999PLC119744 | Cfo | 27 May 2024 | 1999 | ₹872 Cr (FY 2024) | Active |
 Kia Health Tech Private Limited U24239MH2021PTC364174 | Director | 19 Jul 2021 | 2021 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Cipla Pharma And Life Sciences Limited U24239MH2008PLC381559 | Director | 09 Feb 2015 | 2008 | ₹1,598 Cr (FY 2025) | Active |
 Cipla Health Limited U24100MH2015PLC267880 | Cfo | 20 May 2019 | 2015 | ₹1,229 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Nitin Jajodia
| Name | DIN | Company | Designation |
|---|---|---|---|
| Changavalli Venkat | 02391159 | Rubicon Research Limited | Director |
| Deepashree Omkar Tanksale | Rubicon Research Limited | Company Secretary | |
| Kumarapuram Gopalakrishnan Ananthakrishnan | 00019325 | Rubicon Research Limited | Director |
| Milind Anil Patil | 02546815 | Rubicon Research Limited | Director |
| Parag Suganchand Sancheti | Rubicon Research Limited | Ceo | |
| Parag Suganchand Sancheti | 07686819 | Rubicon Research Limited , Kia Health Tech Private Limited | Director |
| Pradnya Nandkumar Saravade | 08472973 | Rubicon Research Limited | Director |
| Pratibha Sudhir Pilgaonkar | 00401516 | Rubicon Research Limited | Managing Director |
| Shantanu Rastogi | 06732021 | Rubicon Research Limited | Director |
| Varun Talukdar | 08312687 | Rubicon Research Limited | Director |
| Sumant Sudhir Pilgaonkar | 07725233 | Kia Health Tech Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nitin Jajodia
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nitin Jajodia
Nitin Jajodia currently holds 2 directorships: Rubicon Research Limited (Cfo, since 27 May 2024, revenue ₹872 Cr (FY 2024)); Kia Health Tech Private Limited (Director, since 19 Jul 2021).
Nitin Jajodia was first appointed on 09 Feb 2015 as Director at Cipla Pharma And Life Sciences Limited. The most recent appointment on record is 27 May 2024 at Rubicon Research Limited.
Nitin Jajodia held 2 earlier board appointments: Cipla Pharma And Life Sciences Limited (Director, 09 Feb 2015 to 01 Apr 2017); Cipla Health Limited (Cfo, 20 May 2019 to 01 Jul 2020).
The current boards of Nitin Jajodia's companies include Changavalli Venkat (Rubicon Research Limited), Deepashree Omkar Tanksale (Rubicon Research Limited), Kumarapuram Gopalakrishnan Ananthakrishnan (Rubicon Research Limited), Milind Anil Patil (Rubicon Research Limited), Parag Suganchand Sancheti (Rubicon Research Limited), Parag Suganchand Sancheti (Rubicon Research Limited), among others.